Form 4: Vanda Pharmaceuticals Director Sells 5,000 Shares

Stephen Ray Mitchell, a director at Vanda Pharmaceuticals, sold 5,000 shares of common stock at an average price of $5.1726 on November 14, 2024.

Summary

• Stephen Ray Mitchell, a director of Vanda Pharmaceuticals, sold 5,000 shares of the company's common stock on November 14, 2024.
• The shares were sold at a weighted average price of $5.1726 per share.
• The sale was executed in multiple transactions with prices ranging from $5.15 to $5.195 per share.
• Following the transaction, Mitchell directly owns 44,857 shares of Vanda Pharmaceuticals.

Sentiment

Score: 5

Explanation: The document is a neutral report of a stock sale by a director, with no indication of positive or negative sentiment.

Industry Context

This is a routine Form 4 filing, which is common for corporate insiders who trade company stock. It provides transparency into the trading activities of company directors.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
• The sale of 5,000 shares by a director is not unusual and is within the normal range of insider transactions.
• Comparable companies also have directors and officers who regularly file Form 4s when they buy or sell shares.

Stakeholder Impact

• The stock sale by a director may have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's operations or financial position.

Key Dates

Keywords

Vanda Pharmaceuticals, insider trading, stock sale, director, Stephen Ray Mitchell, VNDA